# GoHealth (GOCO) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/GOCO
## Company Profile
- Ticker: GOCO
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 0.305 USD
- Market cap: 12364636.479 USD
- Last updated: 2026-06-15
## Business Overview
### Medicare Marketplace
GoHealth operates a technology-enabled marketplace that helps consumers compare and enroll in Medicare and other health-insurance products. Licensed agents support customers through plan selection and application submission.
### Data-Driven Matching
The company’s platform uses machine learning and more than two decades of insurance-purchasing behavior to match consumer needs with available health plans. The goal is to improve fit, retention and conversion compared with a less personalized brokerage process.
### Distribution Models
GoHealth generates submissions through its own licensed agents and through partner-transfer models such as Encompass. It also offers GoHealth Protect products, giving the platform multiple channels and product types within senior-focused insurance distribution.
## Why The Stock Is Moving

Current closing-price context is not available for GOCO.

## Future Catalysts

- GoHealth’s catalysts are Medicare Advantage enrollment, lead-gen execution, and profitability improvement. The market will care about whether the distribution platform can keep turning traffic into durable economics.

## Recent News
- 2026-07-21 20:12 EST — [GoHealth Successfully Completes Financial Restructuring and Emerges Well Positioned for Future Success](https://biopharmsignal.com/news/GOCO/gohealth-successfully-completes-financial-restructuring-and-emerges-well-positio-242faf08) — Source: GoHealth
- 2026-06-07 19:40 EST — [GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders](https://biopharmsignal.com/news/GOCO/gohealth-inc-to-strengthen-its-position-ahead-of-aep-2026-through-restructuring--56003736) — Source: GoHealth
- 2026-03-31 20:20 EST — [GoHealth Prioritizes Consumer Fit, Renewal Economics and Cash Discipline While Continuing Leadership in Special Needs Plans; Reports Full Year 2025 Results](https://biopharmsignal.com/news/GOCO/gohealth-prioritizes-consumer-fit-renewal-economics-and-cash-discipline-while-co-2b57e179) — Source: GoHealth
- 2025-11-13 12:00 EST — [GoHealth Prioritizes Retention, Quality, and Strategic Flexibility as Medicare Advantage Market Rationalizes; Reports Third Quarter 2025 Results](https://biopharmsignal.com/news/GOCO/gohealth-prioritizes-retention-quality-and-strategic-flexibility-as-medicare-adv-16f7a495) — Source: GoHealth
- 2025-11-11 14:00 EST — [GoHealth to Announce Third Quarter 2025 Results on November 13, 2025](https://biopharmsignal.com/news/GOCO/gohealth-to-announce-third-quarter-2025-results-on-november-13-2025-67798cda) — Source: GoHealth